title: [Comparison of the performance of the ECLusys anti-HCV reagent with the Lumipulse f and HISCL 2000-i HCVAb assays].
abstract: We compared the ECLusys Anti-HCV (ECL) reagent to the Lumipulse f (LPf) and HISCL (HIS) HCV assays. In a correlation test using 210 routine clinical specimens measured using the Lumipulse method (96 positive and 114 negative), most of the results were consistent for all specimens. In a dilution sensitivity test using three different routine positive specimens, the ECL assay enabled detection at higher levels of sensitivity than either the LPf or the HIS assay. Moreover, when the distribution of the cut-off index (C.O.I.) values of the routine LPf negative specimens were compared to those on the ECL and HIS assays, it was found that on the ECL assay, most of the specimens had cut-off index values < 0.1, indicating a more clear-cut distribution. In a specificity test using high RF positive specimens(n = 33), pregnancy specimens (n = 35), cytomegalovirus (CMV) antibody positive specimens (n = 36), and high M protein positive specimens (n = 21), the ECL assay yielded positive results for a CMV antibody positive specimen and three high M protein positive specimens. Further testing using samples from the same patients collected on different days than these four samples resulted in a second positive result for the CMV positive specimen, and single antigen measurement yielded a Core/NS3 positive result, as well, suggesting past infection. However, since negative results were obtained for the three M protein positive specimens, the possibility of this being a ECLusys non-specific reaction could not be ruled out. The above results confirmed that the ECL assay provides superior fundamental performance, and possesses test performance nearly identical to that of the existing measurement methods that are widely used at a large number of facilities, and would therefore be a suitable assay for use in routine HCV antibody screening.
authors.affiliation: Department of Laboratory Medicine, Hamamatsu University School of Medicine, Hamamatsu 431-3125, Japan.
authors.forename: Aya
authors.initials: A
authors.lastname: Sugiura
authors.forename: Kunihiro
authors.initials: K
authors.lastname: Iwahara
authors.forename: Yasuyuki
authors.initials: Y
authors.lastname: Suga
authors.forename: Sachinori
authors.initials: S
authors.lastname: Uchiyama
authors.forename: Masato
authors.initials: M
authors.lastname: Maekawa
mesh_terms: D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods*; D018937:Hepatitis C Antibodies / Q000097:blood* / Q000276:immunology*; D018936:Hepatitis C Antigens / Q000276:immunology*; D006801:Humans; D015203:Reproducibility of Results
chemical_list: D018937:Hepatitis C Antibodies; D018936:Hepatitis C Antigens